Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Feb 23, 2021
Date Accepted: Aug 1, 2021

The final, peer-reviewed published version of this preprint can be found here:

An mHealth App to Support Fertility Patients Navigating the World of Infertility (Infotility): Development and Usability Study

Kruglova K, O'Connell SBL, Dawadi S, Gelgoot EN, Miner SA, Robins S, Schinazi J, Zelkowitz P

An mHealth App to Support Fertility Patients Navigating the World of Infertility (Infotility): Development and Usability Study

JMIR Form Res 2021;5(10):e28136

DOI: 10.2196/28136

PMID: 34636741

PMCID: 8548975

Infotility, a Mobile Health Application to Support Fertility Patients in Navigating the World of Infertility: Development and Usability Study

  • Katya Kruglova; 
  • Siobhan Bernadette Laura O'Connell; 
  • Shrinkhala Dawadi; 
  • Eden Noah Gelgoot; 
  • Skye A. Miner; 
  • Stephanie Robins; 
  • Joy Schinazi; 
  • Phyllis Zelkowitz

ABSTRACT

Background:

The experience of infertility and its treatment engenders considerable stress, and is often described as an emotional rollercoaster. A mobile health application (mHealth app) may be a novel solution to address the psychoeducational and psychosocial support needs of fertility patients due to its potential to reduce stress and increase patient empowerment. However, there are few fertility-related apps that provide information and support to both men and women undergoing fertility treatment, and none have documented their development and evaluation process.

Objective:

This study aimed to describe the development and evaluation process of a bilingual mHealth app, Infotility, designed to meet the psychoeducational and psychosocial support needs of men and women undergoing fertility treatment.

Methods:

To develop the Infotility app, we adhered to the Medical Research Council guidelines for the development and evaluation of complex interventions. First, we conducted literature reviews and needs assessment surveys of fertility patients and healthcare providers that informed the content and design of the app. Second, we tested the intervention with a small group of end-users who gave feedback on the design and appropriateness of the app’s content. Third, we evaluated the uptake and usability of the app using a pre/post study design. Fourth, we updated the app’s content based on the participants’ feedback and searched for partners to disseminate the app to the broader public.

Results:

This study is the first to describe the development and evaluation process of the mHealth app for men and women undergoing fertility treatment. The app met its goal in providing fertility patients with: 1) a clinician-approved, portable resource for reliable information about medical and psychosocial aspects of infertility and its treatments; and 2) a confidential peer support forum monitored by trained peer supporters.

Conclusions:

By documenting the systematic development and evaluation of the mHealth app for men and women undergoing fertility treatment, this paper can facilitate replications of the study intervention and the development of similar mHealth apps.


 Citation

Please cite as:

Kruglova K, O'Connell SBL, Dawadi S, Gelgoot EN, Miner SA, Robins S, Schinazi J, Zelkowitz P

An mHealth App to Support Fertility Patients Navigating the World of Infertility (Infotility): Development and Usability Study

JMIR Form Res 2021;5(10):e28136

DOI: 10.2196/28136

PMID: 34636741

PMCID: 8548975

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.